Posted on 09/14/2024 6:42:15 AM PDT by Libloather
The FDA has just written a letter to pharma-giant AbbVie, asking the company to cease running an advertisement for a migraine drug that features tennis legend Serena Williams.
The letter details that the advertisement for Ubrelvy 'makes false or misleading representations' about the drug, and might lead migraine patients to believe that, 'all patients who take Ubrelvy can expect their migraine pain to be eliminated after a single dose of Ubrelvy, when this has not been demonstrated'.
It asks the company to come up with a plan to cease running the advertisement or discontinue distribution of the drug.
AbbVie reported that sales from Ubrelvy and a similar migraine medication called Qulipta, generated $1.223billion in revenue for the company in 2023.
This is not the first time the agency has raised concerns about advertising Ubrelvy. The company that originally promoted the drug, Allergen, was hit with a similiar letter before they were acquired by AbbVie in 2019.
Ms Williams, who has won more Grand Slam single titles than any player in the Open area, has shared previously that she suffers from migraines.
The tennis legend told People in 2021 that her migraines became debilitating during the pandemic, and that found relief in the medication, which must be prescribed by a doctor.
(Excerpt) Read more at dailymail.co.uk ...
Like the FDA has any credibility. They have been misleading for years. Fix thy self, FDA.
“AbbVie reported that sales from Ubrelvy and a similar migraine medication called Qulipta, generated $1.223billion in revenue for the company in 2023.”
No wonder Big Pharma funds Congress!
The FDA - yes, they are always the source of so much accurate information, NOT.
AbbVie, Ubrelvy, Qulipta...English please!
I wonder if this is a case where the drug company didn’t pay the appropriate kickbacks or hire enough former FDA employees. Maybe they thought hiring a diversity spokesperson was enough.
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.